Diagnostic Company LumiraDX Goes Public In $5Bn SPAC Merger
Executive Summary
LumiraDX secured $400m in new debt financing and will use all proceeds to fund growth.
You may also be interested in...
CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal
The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.
Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.